Pemphigus clinical trials
The registry lists 75 studies for Pemphigus across more than 10 countries. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-01.
Status
- Completed
- 27
- Status unknown
- 13
- Terminated
- 13
- Recruiting
- 9
- Not yet recruiting
- 8
- Active, not recruiting
- 3
Phase
- Phase 2
- 23
- Phase 3
- 16
- Phase 1
- 7
- Phase 4
- 3
- Early Phase 1
- 2
Where
- United States
- 25
- France
- 15
- China
- 11
- Israel
- 10
- Germany
- 7
- Australia
- 7
Who runs them
University Hospital, Rouen (6) · Assiut University (5) · Cairo University (3) · argenx (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Chao Ji (2) · Ruijin Hospital (2) · Hoffmann-La Roche (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 75 — search for more.
- Compassionate Use or Expanded Access of DupilumabAvailableNCT04776694
- Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus VulgarisNot yet recruitingNCT07769333Early Phase 1
- CD19 CAR-T Therapy for Refractory Pemphigus VulgarisRecruitingNCT07681388Not applicable1 country
- A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)RecruitingNCT04422912Phase 1/21 country
- A Clinical Study of B007 in the Treatment of Pemphigus.RecruitingNCT06454357Phase 2/31 country
- Autoimmune Blistering Diseases StudyRecruitingNCT027537771 country
- Comparison of a Personalized Maintenance Therapy With the Standard Treatment in PemphigusRecruitingNCT05898308Phase 42 countries
- FARD (RaDiCo Cohort) (RaDiCo-FARD)RecruitingNCT059544161 country
- Periodontal Status and Disease Severity in Pemphigus Vulgaris PatientsRecruitingNCT073842211 country
- Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.Not yet recruitingNCT06971172Not applicable
- A Single-center Study of CM313 in Patients With PemphigusNot yet recruitingNCT06904040Not applicable1 country
- Impact of a Lifestyle Program on Quality of Life in Pemphigus PatientsNot yet recruitingNCT06901427Not applicable
- Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.Not yet recruitingNCT06863454
- A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.Not yet recruitingNCT06663943Phase 1/2
- Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.RecruitingNCT06581562Phase 11 country
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesRecruitingNCT056352661 country
- Coagulation Activation in Patients With PemphigusNot yet recruitingNCT06285435
- Evaluation of Galectin-3 in Serum and Saliva of Pemphigus PatientsNot yet recruitingNCT05992727
- ONO-4059 Study in Patients With Steroid-resistant PemphigusActive, not recruitingNCT06696716Phase 31 country
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 21 country
- Effect of Topical Insulin on Healing Rate of Pemphigus LesionsCompletedNCT07461103Phase 21 country
- Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus PatientsCompletedNCT074579441 country
- Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsCompletedNCT074289151 country
- Identification of Vulnerability Factors in the Course of Pemphigus PatientsCompletedNCT02237313Not applicable1 country
- IVIG With Rituximab vs Rituximab as First Line Treatment of PemphigusActive, not recruitingNCT04400994Phase 21 country
- A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral CenterActive, not recruitingNCT069492411 country
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)TerminatedNCT04598477Phase 321 countries
- Assessment of the 1-year Relapse Rate in Patients with Pemphigus Treated According to the Revised Pemphigus PNDSCompletedNCT069034941 country
- Comparing DCP and DAP for Pemphigus VulgarisCompletedNCT06846255Phase 41 country
- Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus VulgarisCompletedNCT066548171 country
- A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)CompletedNCT04598451Phase 321 countries
- Polyclonal Regulatory T Cells (PolyTregs) for PemphigusTerminatedNCT03239470Phase 11 country
- Dexamethasone Solution and Dexamethasone in Mucolox™CompletedNCT04540133Phase 21 country
- Identifying Factors Influencing In-Hospital Relapse in Pemphigus PatientsCompletedNCT061674081 country
- A Study of PRN1008 in Patients With PemphigusTerminatedNCT03762265Phase 319 countries
- Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease ActivityStatus unknownNCT053381121 country
- A Study of PRN1008 in Adult Patients With Pemphigus VulgarisCompletedNCT02704429Phase 25 countries
- Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous PemphigoidStatus unknownNCT05594472Phase 31 country
- Validation of 5-Point Investigator Global Assessments for PemphigusStatus unknownNCT055347767 countries
- Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris PatientsStatus unknownNCT040962221 country
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)Status unknownNCT05303272Phase 41 country
- Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian PopulationStatus unknownNCT052849291 country
- Study of Efficacy and Safety of VAY736 in Patients With Pemphigus VulgarisTerminatedNCT01930175Phase 24 countries
- Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus VulgarisStatus unknownNCT04023149Phase 21 country
- Phenotypic and Functional Characterisation of Human B-cell Response in PemphigusStatus unknownNCT04117529Not applicable1 country
- A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With PemphigusCompletedNCT03334058Phase 25 countries
- A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)CompletedNCT02383589Phase 312 countries
- A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)TerminatedNCT03075904Phase 1/21 country
- A Study of the Safety and Tolerability of INCB050465 in Pemphigus VulgarisWithdrawnNCT03780166Phase 2
- Efficacy and Safety of Ofatumumab in Treatment of Pemphigus VulgarisTerminatedNCT01920477Phase 38 countries